OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey

According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointesti...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2016-06, Vol.117, p.S22-S23
Main Authors: Yiginer, Omer, Erdal, Emrah, Acar, Gurkan, Cay, Serkan, Ergelen, Mehmet, Cetin, Hande, Tezcan, Mehmet, Dogan, Mehmet, Un, Haluk, Ozcelik, Fatih, Degirmencioglu, Gokhan, Tokatli, Alptug
Format: Article
Language:English
Subjects:
Anticoagulants
Cardiovascular
Coagulation
Hemorrhage
Thromboembolism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S23
container_issue
container_start_page S22
container_title The American journal of cardiology
container_volume 117
creator Yiginer, Omer
Erdal, Emrah
Acar, Gurkan
Cay, Serkan
Ergelen, Mehmet
Cetin, Hande
Tezcan, Mehmet
Dogan, Mehmet
Un, Haluk
Ozcelik, Fatih
Degirmencioglu, Gokhan
Tokatli, Alptug
description According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointestinal Hemorrhage 7 4 n.s. Minor Hemorrhage 10 14 n.s. The Clinical Events During the Usage of New Oral Anticoagulants
doi_str_mv 10.1016/j.amjcard.2016.04.095
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1797608785</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914916306178</els_id><sourcerecordid>4092433061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1855-ca72686a502a519d1d2f5c9e79f2815d54ea1a2128e982bf2dc90fc1069d8c1d3</originalsourceid><addsrcrecordid>eNqFkU9LAzEQxYMoWP98BCHgeddM2uwmF0XEqiBWtOIxxGRWs667Ndmq_famtiB48TQMvPdm5jeEHADLgUFxVOfmrbYmuJynNmejnCmxQQYgS5WBguEmGTDGeKZgpLbJTox1agFEMSCTyW3GhKDTF6RjH2JP79A02WMXGkfPv2YYPLYWaVfRPklu8JNOgmnoadt725nneWPaPlLf0uk8vOJij2xVpom4v6675GF8Pj27zK4nF1dnp9eZBSlEZk3JC1kYwbgRoBw4XgmrsFQVlyCcGKEBw4FLVJI_VdxZxSoLrFBOWnDDXXK4yp2F7n2Osdd1Nw9tGqmhVGXBZClFUomVyoYuxoCVngX_ZsJCA9NLdrrWa3Z6yU6zkU7sku9k5cN0wofHoKP94eB8QNtr1_l_E47_JNjGt96aJkHC-Lusjlwzfb_8z_I9UAxZAaUcfgOQv4zN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1797608785</pqid></control><display><type>article</type><title>OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Yiginer, Omer ; Erdal, Emrah ; Acar, Gurkan ; Cay, Serkan ; Ergelen, Mehmet ; Cetin, Hande ; Tezcan, Mehmet ; Dogan, Mehmet ; Un, Haluk ; Ozcelik, Fatih ; Degirmencioglu, Gokhan ; Tokatli, Alptug</creator><creatorcontrib>Yiginer, Omer ; Erdal, Emrah ; Acar, Gurkan ; Cay, Serkan ; Ergelen, Mehmet ; Cetin, Hande ; Tezcan, Mehmet ; Dogan, Mehmet ; Un, Haluk ; Ozcelik, Fatih ; Degirmencioglu, Gokhan ; Tokatli, Alptug</creatorcontrib><description>According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointestinal Hemorrhage 7 4 n.s. Minor Hemorrhage 10 14 n.s. The Clinical Events During the Usage of New Oral Anticoagulants</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2016.04.095</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Anticoagulants ; Cardiovascular ; Coagulation ; Hemorrhage ; Thromboembolism</subject><ispartof>The American journal of cardiology, 2016-06, Vol.117, p.S22-S23</ispartof><rights>2016</rights><rights>Copyright Elsevier Limited Jun 2, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Yiginer, Omer</creatorcontrib><creatorcontrib>Erdal, Emrah</creatorcontrib><creatorcontrib>Acar, Gurkan</creatorcontrib><creatorcontrib>Cay, Serkan</creatorcontrib><creatorcontrib>Ergelen, Mehmet</creatorcontrib><creatorcontrib>Cetin, Hande</creatorcontrib><creatorcontrib>Tezcan, Mehmet</creatorcontrib><creatorcontrib>Dogan, Mehmet</creatorcontrib><creatorcontrib>Un, Haluk</creatorcontrib><creatorcontrib>Ozcelik, Fatih</creatorcontrib><creatorcontrib>Degirmencioglu, Gokhan</creatorcontrib><creatorcontrib>Tokatli, Alptug</creatorcontrib><title>OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey</title><title>The American journal of cardiology</title><description>According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointestinal Hemorrhage 7 4 n.s. Minor Hemorrhage 10 14 n.s. The Clinical Events During the Usage of New Oral Anticoagulants</description><subject>Anticoagulants</subject><subject>Cardiovascular</subject><subject>Coagulation</subject><subject>Hemorrhage</subject><subject>Thromboembolism</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqFkU9LAzEQxYMoWP98BCHgeddM2uwmF0XEqiBWtOIxxGRWs667Ndmq_famtiB48TQMvPdm5jeEHADLgUFxVOfmrbYmuJynNmejnCmxQQYgS5WBguEmGTDGeKZgpLbJTox1agFEMSCTyW3GhKDTF6RjH2JP79A02WMXGkfPv2YYPLYWaVfRPklu8JNOgmnoadt725nneWPaPlLf0uk8vOJij2xVpom4v6675GF8Pj27zK4nF1dnp9eZBSlEZk3JC1kYwbgRoBw4XgmrsFQVlyCcGKEBw4FLVJI_VdxZxSoLrFBOWnDDXXK4yp2F7n2Osdd1Nw9tGqmhVGXBZClFUomVyoYuxoCVngX_ZsJCA9NLdrrWa3Z6yU6zkU7sku9k5cN0wofHoKP94eB8QNtr1_l_E47_JNjGt96aJkHC-Lusjlwzfb_8z_I9UAxZAaUcfgOQv4zN</recordid><startdate>20160602</startdate><enddate>20160602</enddate><creator>Yiginer, Omer</creator><creator>Erdal, Emrah</creator><creator>Acar, Gurkan</creator><creator>Cay, Serkan</creator><creator>Ergelen, Mehmet</creator><creator>Cetin, Hande</creator><creator>Tezcan, Mehmet</creator><creator>Dogan, Mehmet</creator><creator>Un, Haluk</creator><creator>Ozcelik, Fatih</creator><creator>Degirmencioglu, Gokhan</creator><creator>Tokatli, Alptug</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20160602</creationdate><title>OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey</title><author>Yiginer, Omer ; Erdal, Emrah ; Acar, Gurkan ; Cay, Serkan ; Ergelen, Mehmet ; Cetin, Hande ; Tezcan, Mehmet ; Dogan, Mehmet ; Un, Haluk ; Ozcelik, Fatih ; Degirmencioglu, Gokhan ; Tokatli, Alptug</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1855-ca72686a502a519d1d2f5c9e79f2815d54ea1a2128e982bf2dc90fc1069d8c1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anticoagulants</topic><topic>Cardiovascular</topic><topic>Coagulation</topic><topic>Hemorrhage</topic><topic>Thromboembolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yiginer, Omer</creatorcontrib><creatorcontrib>Erdal, Emrah</creatorcontrib><creatorcontrib>Acar, Gurkan</creatorcontrib><creatorcontrib>Cay, Serkan</creatorcontrib><creatorcontrib>Ergelen, Mehmet</creatorcontrib><creatorcontrib>Cetin, Hande</creatorcontrib><creatorcontrib>Tezcan, Mehmet</creatorcontrib><creatorcontrib>Dogan, Mehmet</creatorcontrib><creatorcontrib>Un, Haluk</creatorcontrib><creatorcontrib>Ozcelik, Fatih</creatorcontrib><creatorcontrib>Degirmencioglu, Gokhan</creatorcontrib><creatorcontrib>Tokatli, Alptug</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest_Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yiginer, Omer</au><au>Erdal, Emrah</au><au>Acar, Gurkan</au><au>Cay, Serkan</au><au>Ergelen, Mehmet</au><au>Cetin, Hande</au><au>Tezcan, Mehmet</au><au>Dogan, Mehmet</au><au>Un, Haluk</au><au>Ozcelik, Fatih</au><au>Degirmencioglu, Gokhan</au><au>Tokatli, Alptug</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey</atitle><jtitle>The American journal of cardiology</jtitle><date>2016-06-02</date><risdate>2016</risdate><volume>117</volume><spage>S22</spage><epage>S23</epage><pages>S22-S23</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointestinal Hemorrhage 7 4 n.s. Minor Hemorrhage 10 14 n.s. The Clinical Events During the Usage of New Oral Anticoagulants</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.amjcard.2016.04.095</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2016-06, Vol.117, p.S22-S23
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_journals_1797608785
source ScienceDirect Freedom Collection 2022-2024
subjects Anticoagulants
Cardiovascular
Coagulation
Hemorrhage
Thromboembolism
title OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A51%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OP-055%20The%20First%20Real-World%20Experience%20of%20the%20New%20Oral%20Anticoagulants%20in%20Turkey&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Yiginer,%20Omer&rft.date=2016-06-02&rft.volume=117&rft.spage=S22&rft.epage=S23&rft.pages=S22-S23&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2016.04.095&rft_dat=%3Cproquest_cross%3E4092433061%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1855-ca72686a502a519d1d2f5c9e79f2815d54ea1a2128e982bf2dc90fc1069d8c1d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1797608785&rft_id=info:pmid/&rfr_iscdi=true